MIS Stock Overview
Provides assisted reproductive and specialist women imaging services in Australia and Malaysia.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Monash IVF Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.70 |
| 52 Week High | AU$0.93 |
| 52 Week Low | AU$0.67 |
| Beta | 1.41 |
| 11 Month Change | -2.78% |
| 3 Month Change | -13.58% |
| 1 Year Change | -5.41% |
| 33 Year Change | 20.69% |
| 5 Year Change | 12.00% |
| Change since IPO | -39.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| MIS | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.5% | -1.2% |
| 1Y | -5.4% | 18.3% | 9.0% |
Return vs Industry: MIS underperformed the German Healthcare industry which returned 25.2% over the past year.
Return vs Market: MIS underperformed the German Market which returned 13.5% over the past year.
Price Volatility
| MIS volatility | |
|---|---|
| MIS Average Weekly Movement | 6.4% |
| Healthcare Industry Average Movement | 3.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: MIS has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: MIS's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2024 | 997 | Michael Knaap | www.monashivfgroup.com.au |
Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services.
Monash IVF Group Limited Fundamentals Summary
| MIS fundamental statistics | |
|---|---|
| Market cap | €279.40m |
| Earnings (TTM) | -€4.02m |
| Revenue (TTM) | €157.09m |
1.8x
P/S Ratio-69.5x
P/E RatioIs MIS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MIS income statement (TTM) | |
|---|---|
| Revenue | AU$255.23m |
| Cost of Revenue | AU$169.46m |
| Gross Profit | AU$85.77m |
| Other Expenses | AU$92.29m |
| Earnings | -AU$6.53m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.017 |
| Gross Margin | 33.60% |
| Net Profit Margin | -2.56% |
| Debt/Equity Ratio | 24.1% |
How did MIS perform over the long term?
See historical performance and comparison